GeneMatrix Inc. (KOSDAQ:109820)

GeneMatrix Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	May 13, 2025	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Market Capitalization	48,128	67,826	36,417	52,200	27,055	20,697
Market Cap Growth	-24.50%	86.25%	-30.23%	92.94%	30.72%	41.31%
Enterprise Value	-	66,562	33,653	49,976	27,289	21,064
Last Close Price	2360.00	4230.00	2376.67	3406.67	2153.33	1653.33
PS Ratio	10.19	14.33	7.02	10.28	5.09	3.10
PB Ratio	3.10	5.95	3.05	3.84	2.70	1.74
P/TBV Ratio	3.27	6.31	3.32	4.22	3.20	2.14
EV/Sales Ratio	-	14.06	6.49	9.84	5.13	3.16
Debt / Equity Ratio	0.70	1.51	0.34	0.30	0.87	0.31
Asset Turnover	0.17	0.19	0.28	0.25	0.28	0.36
Inventory Turnover	2.35	2.96	3.78	3.29	2.19	2.39
Quick Ratio	1.80	1.18	1.97	2.25	2.44	1.63
Current Ratio	2.02	1.27	2.21	2.43	2.70	2.03
Return on Equity (ROE)	-15.62%	-28.16%	-13.58%	-34.56%	-21.74%	-9.03%
Return on Assets (ROA)	-6.05%	-7.12%	-5.94%	-12.40%	-7.16%	-4.50%
Return on Capital (ROIC)	-6.71%	-7.86%	-6.53%	-13.64%	-7.88%	-5.07%
Earnings Yield	-4.35%	-4.58%	-4.04%	-7.24%	-7.47%	-5.42%
FCF Yield	-6.01%	-4.54%	-5.37%	-1.23%	-2.48%	-7.92%
Buyback Yield / Dilution	-65.60%	-50.20%	24.88%	-8.06%	-0.78%	0.24%

Updated Nov 13, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.